Viral Therapy in Treating Patients With Relapsed or Refractory Multiple Myeloma

Clinical trial NCT01533194 · COMPLETED

Trial details

NCT number: NCT01533194
Sponsor: National Cancer Institute (NCI)
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Light Chain Deposition Disease Refractory Plasma Cell Myeloma

Start date: 2012-04-01
Primary completion: 2015-02-01
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.